Next Article in Journal
Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation
Previous Article in Journal
Understanding the Mechanisms of Action and Effects of Drugs of Abuse
Previous Article in Special Issue
Dracocephalum jacutense Peschkova from Yakutia: Extraction and Mass Spectrometric Characterization of 128 Chemical Compounds
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 13
10.3390/molecules28134972
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Quinone Pool, a Key Target of Plant Flavonoids Inhibiting Gram-Positive Bacteria

by
Li Zhang
1,2,†,
Yu Yan
1,†,
Jianping Zhu
2,†,
Xuexue Xia
1,
Ganjun Yuan
1,2,*,
Shimin Li
2,
Beibei Deng
2 and
Xinrong Luo
2
1
Biotechnological Engineering Center for Pharmaceutical Research and Development, Jiangxi Agricultural University, Nanchang 330045, China
2
Laboratory of Natural Medicine and Microbiological Drug, College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang 330045, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Molecules 2023, 28(13), 4972; https://doi.org/10.3390/molecules28134972
Submission received: 18 May 2023 / Revised: 20 June 2023 / Accepted: 22 June 2023 / Published: 24 June 2023
(This article belongs to the Special Issue Chemistry, Biology, and Pharmacology of Natural Phenolic Compounds and Their Synthetic Derivatives)
Browse Figures
Review Reports Versions Notes

Abstract

:
Plant flavonoids have attracted increasing attention as new antimicrobial agents or adjuvants. In our previous work, it was confirmed that the cell membrane is the major site of plant flavonoids acting on the Gram-positive bacteria, which likely involves the inhibition of the respiratory chain. Inspired by the similar structural and antioxidant characters of plant flavonoids to hydro-menaquinone (MKH2), we deduced that the quinone pool is probably a key target of plant flavonoids inhibiting Gram-positive bacteria. To verify this, twelve plant flavonoids with six structural subtypes were preliminarily selected, and their minimum inhibitory concentrations (MICs) against Gram-positive bacteria were predicted from the antimicrobial quantitative relationship of plant flavonoids to Gram-positive bacteria. The results showed they have different antimicrobial activities. After their MICs against Staphylococcus aureus were determined using the broth microdilution method, nine compounds with MICs ranging from 2 to 4096 μg/mL or more than 1024 μg/mL were eventually selected, and then their MICs against S. aureus were determined interfered with different concentrations of menaquinone−4 (MK−4) and the MKs extracted from S. aureus. The results showed that the greater the antibacterial activities of plant flavonoids were, the more greatly their antibacterial activities decreased along with the increase in the interfering concentrations of MK−4 (from 2 to 256 μg/mL) and the MK extract (from 4 to 512 μg/mL), while those with the MICs equal to or more than 512 μg/mL decreased a little or remained unchanged. In particular, under the interference of MK−4 (256 μg/mL) and the MK extract (512 μg/mL), the MICs of α-mangostin, a compound with the greatest inhibitory activity to S. aureus out of these twelve plant flavonoids, increased by 16 times and 8 to 16 times, respectively. Based on the above, it was proposed that the quinone pool is a key target of plant flavonoids inhibiting Gram-positive bacteria, and which likely involves multiple mechanisms including some enzyme and non-enzyme inhibitions.

1. Introduction

Antimicrobial resistance (AMR) has brought about a serious threat to public health and economic development, and the COVID-19 pandemic has further accelerated this global problem [1]. Therefore, new antimicrobial agents are being desperately developed [2,3]. Most antibiotics bring about some adverse reactions to the human body during their treatment on bacterial infection, and eventually also become resistant to pathogenic bacteria after a period of use in clinic [4]. However, some plant secondary metabolites not only have antimicrobial activities, but also show a good level of safety for the human body since they exist in all sorts of plant-derived foods and beverages [5,6]. Among them, close attention has been paid to plant flavonoids [7,8,9,10,11].
Flavonoids are an important class of secondary metabolites widely distributed in various plants, and approximately 10,000 compounds have been discovered so far. Many of them show different degrees of inhibitory activity to pathogenic bacteria, especially Gram-positive ones, and some of them can also enhance the inhibitory effect of some antimicrobial agents and/or even reverse the AMR [12,13]. Simultaneously, various antibacterial mechanisms were reported for plant flavonoids [7,9,12], which involved the synthesis inhibitions to DNA, proteins and cell envelope, the damage of cell membrane, and so on. Recently, Yuan et al. confirmed that the cell membrane is the major site of plant flavonoids acting on the Gram-positive bacteria, and which includes the damage of phospholipid bilayers and likely involves the inhibition of the respiratory chain, or some others [14,15]. In addition, they pointed out that the antibacterial activities of plant flavonoids to the Gram-positive bacteria are directly related to their lipophilicities, and present nonspecific characterization concluded from the antimicrobial quantitative relationships between the physicochemical parameters and the antimicrobial activities [14,15].
The antimicrobial mechanism of plant flavonoids damaging the phospholipid bilayers of Gram-positive bacteria was confirmed as above, while other mechanisms acting on the cell membrane should be further explored. As Yuan et al. pointed out [14,15], plant flavonoids present a nonspecific antimicrobial mechanism. Therefore, the non-enzyme inhibitions of plant flavonoids to the respiratory chain of Gram-positive bacteria were also our focus, although some probable enzyme mechanisms were likely involved. The compositions of the respiratory chains for different bacteria are varied, while the quinone pool is always a center of electron transfer in the respiratory chain for most bacteria [16,17]. For Gram-positive bacteria, the menaquinone (MK), together with its reducing form as hydro-menaquinone (MKH2), is the sole quinone for the electron transfer in the respiratory chain for Gram-positive bacteria [16,17,18]. Inspired by the similar structural and antioxidant characters of plant flavonoids to MKH2, we deduced that the quinone pool is a key target of plant flavonoids inhibiting Gram-positive bacteria. To confirm this, here, twelve compounds, with seven structural subtypes and various degrees of inhibitory activities, were preliminarily selected for determining the interference of MK−4 (or the MK extract from Staphylococcus aureus) on the inhibitory activities of flavonoids to Gram-positive bacteria.

2. Results

2.1. Calculated and Tested Minimum Inhibitory Concentrations (MICs)

As shown on Figure 1, twelve plant flavonoids, with seven structural subtypes including dihydroflavones, flavonols, flavones, isoflavones, chalcones, flavanes and xanthones, were selected for verifying the inference that the quinone pool is a key target of plant flavonoids inhibiting Gram-positive bacteria. Their average MICs (or MIC90s) against Gram-positive bacteria such as S. aureus, S. epidermidis and Bacillus subtilis were calculated according to Equation (1) in Section 4.3 [15], and the results (Table 1) showed that they had different degrees of inhibitory activities and can be used for further screening to obtain the required flavonoids with different antibacterial activities.
Subsequently, the MICs of these plant flavonoids against S. aureus ATCC 25923 were determined using the broth microdilution method, and the results are also shown in Table 1. From Table 1, it can be seen that these flavonoids present different degrees of inhibitory activity to S. aureus ATCC 25923, with the MIC values ranging from 2 to 4096 (or more than 1024) μg/mL. Considering that selecting plant flavonoids with various structural subtypes and different antimicrobial activities can enhance the scientificity and rationality of the verification experiments, nine plant flavonoids with six subtypes, including α-mangostin, sophoraflavanone G, licochalcone A, kurarinone, glabridin, isoliquiritigenin, baicalein, echinatin and quercetin, were selected for further experiments.
In addition, as observed in Table 1, the results also indicate that the larger the lipophilicities of plant flavonoids, the greater their antimicrobial activities. This confirmed again that the lipophilicity is a key factor of plant flavonoids against Gram-positive bacteria. Furthermore, according to the rules that for the predicted MICs ranging from 1/4× to 4×, the determined ones were acceptable [14,15], and for those less than 1/8× or more than 8×, the determined ones were completely unacceptable, the calculated MIC values of only one plant flavonoid as echinatin was unacceptable, and which once again confirmed the efficiency of Equation (1) for predicting the MICs of plant flavonoids against Gram-positive bacteria.

2.2. Influences of MK−4 on Plant Flavonoids against S. aureus

To verify our hypothesis, MK−4 (menaquinone−4) was selected as a simplified representative for preliminarily exploring the influences of MK−4 on plant flavonoids against S. aureus. The results (Figure 2) showed that the antimicrobial activities of five plant flavonoids (α-mangostin, sophoraflavanone G, licochalcone A, kurarinone and glabridin), with their MICs ranging from 2 to 16 μg/mL, obviously decreased along with the increase in the interfering concentrations (from 2 to 256 μg/mL) of MK−4 (Figure 2a–e). However, those plant flavonoids with MICs over 512 μg/mL decreased a little or were unable to evaluate (Figure 2f–h) for isoliquiritigenin, baicalein and echinatin, and even remained unchanged for quercetin with the MICs of 4098 μg/mL (Figure 2i).
In addition, the MIC changes of plant flavonoids against S. aureus ATCC 25923 after interfering with the MK−4 concentration of 256 μg/mL are listed in Table 2 for obtaining clearer and more intuitive MIC changes.
Thus, the above together indicated that the larger the interfering concentrations of MK are, the more remarkably the antibacterial activities of plant flavonoids decrease. Furthermore, it also indicated that the greater the antibacterial activities of plant flavonoids are, the more obvious the interferences of MK on their antibacterial activities are, and the more greatly their antibacterial activities decrease. Simultaneously, menaquinones are the sole quinones in the quinone pools of Gram-positive bacteria, which do not contain ubiquinones. Therefore, it was inferred that plant flavonoids can target the quinone pools of Gram-positive bacteria, especially S. aureus.

2.3. Influences of MK Extract on Plant Flavonoids against S. aureus

To further confirm the above inference, the MK in the quinone pool of S. aureus ATCC 25923 was extracted according to the method in Section 4.6.1 and was marked as an MK extract. Using MK−4 as an internal standard, the HPLC-UV analyses for the MK extract were performed according to the method in [19]. The representative HPLC profile was shown as Figure 3, and its detailed HPLC-UV profile is shown in Figure S1 in Supplementary Files. Compared with the UV spectroscopy (Figure S1b) of MK−4, for which the retention time is 4.944 min in the HPLC profile (Figure S1a), the results (Figure 3 and Figure S1a) indicated that there are three menaquinones with the retention times, respectively, at 8.463 (peak 1), 10.535 (peak 2) and 13.318 (peak 3) min in the MK extract. As S. aureus mainly contains MK−8 together with a little of MK−7 and −9 in the quinone pool and those MKs have similar physicochemical properties, the main chromatographic peak 2 in the HPLC profile (Figure 3) corresponded to MK−8, and those of peaks 1 and 3 to MK−7 and −9. Therefore, the menaquinones contained in the MK extract were in accordance with those in the quinone pool of S. aureus and can be used for further interfering experiments.
Using this MK extract, the influences of the MK extract on plant flavonoids against S. aureus ATCC 25923 were determined. The results (Figure 4) also showed that the antimicrobial activities of five plant flavonoids (α-mangostin, sophoraflavanone G, licochalcone A, kurarinone and glabridin) with their MICs ranging from 2 to 16 μg/mL obviously decreased along with the increase in the interfering concentrations of MK−4 from 4 to 512 μg/mL (Figure 4a–e). However, those plant flavonoids with the MICs equal to or more than 1024 μg/mL remained unchanged for isoliquiritigenin and quercetin, respectively, with the MICs of 1024 and 4098 μg/mL (Figure 2f,i), or were unable to evaluate (Figure 2g,h) for baicalein and echinatin. This indicated that the greater the antibacterial activities of plant flavonoids, the more greatly their antibacterial activities of plant flavonoids decrease along with the increase in the interfering concentrations of MK extract. Moreover, for those plant flavonoids with their MICs equal to or more than 1024 μg/mL, their MIC values seemed to remain unchanged along with the increase in the MK extract concentrations from 4 to 512 μg/mL.
In addition, the MIC changes of plant flavonoids against S. aureus ATCC 25923 after interfering with the MK−4 concentration of 512 μg/mL are also listed in Table 2 for obtaining clearer and more intuitive change information. From Table 2, can be seen that similar results and rules were presented for the MIC changes of flavonoids inhibiting S. aureus whether interfering with the MK extract or MK−4. Namely, the greater the antibacterial activities of plant flavonoids are, the more obvious the interferences of MK extract on their antibacterial activities are, and the more greatly their antibacterial activities decrease. Therefore, it was further confirmed that the quinone pool is a key target of plant flavonoids against S. aureus since both of the above results of two interfering experiments were obtained from various structural subtypes with different antimicrobial activities.

3. Discussion

In our previous work [14,15], we confirmed that the cell membrane is the main site of plant flavonoids against Gram-positive bacteria, which likely involves respiratory inhibition, etc. Using twelve plant flavonoids including various structural subtypes and different antimicrobial activities, here the interfering experiments of MK−4 and the MK extract from S. aureus confirmed that the quinone pool on the respiratory chain is a key target of plant flavonoids against S. aureus.
Similar to S. aureus, the menaquinones (MKs) are the sole quinones for electron transfer in the respiratory chain of Gram-positive bacteria [16,17]. Simultaneously, the antimicrobial quantitative relationship between the parameters and the antimicrobial activities, together with many publications [8,13,20], indicated that a certain flavonoid has similar antimicrobial activities to various Gram-positive bacteria. Therefore, it can be inferred that plant flavonoids have a similar mechanism targeting the quinone pools in the respiratory chains of Gram-positive bacteria. For Gram-negative bacteria, there are two quinone MKs and ubiquinones in the quinone pools of their respiratory chains [17], which is in accordance with the fact that plant flavonoids show weak antimicrobial activities to Gram-negative bacteria [8,13,20]. Conversely, this further confirmed the reasonability of our initial inference.
From Table 1, it can be seen that plant flavonoids with larger lipophilicity, such as α-mangostin, sophoraflavanone G, licochalcone A and kurarinone, showed obviously stronger antimicrobial activities than those with smaller lipophilicity, and all compounds with a LogP less than 3.40 scarcely presented antibacterial activity. However, this does not mean that the stronger the lipophilicity, the stronger the antibacterial activity. For example, the lipophilicity (LogP, 4.95) of licochalcone A is weaker than that (LogP, 6.30) of kurarinone, while the antimicrobial activities of the former are stronger than that of the latter. Combined with our previous work [14,15], this further showed that it plays a key role in the antibacterial activities of plant flavonoids to have enough lipophilicity for locating the cell membranes of Gram-positive bacteria and targeting the quinone pool on the respiratory chain. This is also the probable reason that the actual antibacterial activities were inconsistent with those obtained from some experiments at the molecular level [21,22,23,24].
During the interfering experiments of MK−4 and the MK extract from S. aureus, some precise MIC data of isoliquiritigenin, baicalein and echinatin were not obtained, and were recorded as more than 1024 μg/mL (Figure 2 and Figure 4) since these flavonoids present too poor a solubility to be effectively determined. However, those of isoliquiritigenin (1024 μg/mL) and quercetin (4096 μg/mL), together with the precise MIC data of other plant flavonoids, already confirmed the MIC change trends of plant flavonoids against Gram-positive bacteria along with the increase in the interfering concentrations of MK−4 or the MK extract. Simultaneously, interfering with the MKs extracted from S. aureus, it more powerfully confirmed that the MK pool is a key target of plant flavonoids against Gram-positive bacteria. Furthermore, it is worth exploring whether there are some other lipophilic components, except MKs and membrane phospholipid, with the potency of interference for plant flavonoids against Gram-positive bacteria.
Among these twelve plant flavonoids, α-mangostin, a xanthone compound from guttiferaeous plants [25,26], showed the greatest inhibitory activity to S. aureus, with an MIC of 2 μg/mL, which is close to the maximum antibacterial activity of plant flavonoids predicted from the antimicrobial quantitative relationship [15]. Therefore, the results from its interfering experiments can best reflect the antibacterial mechanism of plant flavonoids. The results (Table 2) indicate that the MICs of α-mangostin to S. aureus, respectively, increased by 16 times and 8 to 16 times, under the interference of MK−4 (256 μg/mL) and the MK extract (512 μg/mL). Simultaneously, it was reported that α-mangostin can target the bacterial membrane and enhance membrane permeability [27,28,29]. Taken together these powerfully support the idea that the cell membrane is the main site of plant flavonoids against Gram-positive bacteria, involving damage to the phospholipid bilayers and inhibition to the respiratory chain through targeting the quinone pool.
Furthermore, the antimicrobial activities of plant flavonoids decreased along with the interfering concentrations of MK−4 and MK extract. However, this showed that they presented a stepwise decrease (Figure 2 and Figure 3), not a complete dose-dependent S-shaped curve. Therefore, the effects of plant flavonoids on the quinone pool of Gram-positive bacteria likely involve multiple mechanisms including enzyme and non-enzyme inhibition. The enzyme mechanisms probably involved the inhibition to some enzymes on the respiratory chain [30], but not on the synthase of MKs since these are the sole quinones in Gram-positive bacteria. The non-enzyme mechanisms probably included the electron transfer, membrane potential and/or reactive oxygen stress (ROS). However, the real ones should be further explored.

4. Materials and Methods

4.1. Materials, Chemicals and Reagents

Kurarinone (≥98%) was purchased from Wuhan ChemFaces Biochemical Co., Ltd. (Wuhan, China). Sophoraflavanone G (>98%), glabridin (99.8%) and echinatin (98%) were purchased from Shanghai TopScience Co., Ltd. (Shanghai, China). Isoliquirtigenin (98%), formononetin (98%), naringenin (97%), galangin (98%) and baicalin (98%) were purchased from Shanghai Macklin Biochemical Co., Ltd. (Shanghai, China). Quercetin (97%) was purchased from Shanghai Meryer Co., Ltd. (Shanghai, China). Licochalcones A (>98.0%) and α-mangostin (>98.0%) were purchased from Chengdu Push Bio-technology Co., Ltd. (Chengdu, China). All the compounds were stored at −20 °C. The stock solutions of the above plant flavonoids were prepared by dissolving them in dimethyl sulfoxide (DMSO) and diluting them with Mueller Hinton broth (MHB) to obtain a concentration of 4096 μg/mL. The stock solution was mixed well and then diluted to the desired concentrations with MHB immediately before use. In another, the DMSO concentrations in all the test systems were kept to less than 5.0%, and all those in the blank controls were 5.0%.
MK−4 was purchased from Sigma-Aldrich (St. Louis, MO, USA). Methanol and petroleum ether used for the MK extract from S. aureus were obtained from Xilong Scientific Co., Ltd. (Shantou, China). Casein hydrolysate (Qingdao Hope Bio-Technology Co., Ltd., Qingdao, China), starch soluble (Xilong Scientific Co., Ltd., Shantou, China), beef extract and agar powder (Sangon Biotech (Shanghai) Co., Ltd., Shanghai, China) were used for preparing the media. DMSO was purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Thiazolyl blue tetrazolium bromide was purchased from Sangon Biotech (Shanghai) Co., Ltd. (Shanghai, China), and the 96-well plates were purchased from Shanghai Excell Biological Technology Co., Ltd. (Shanghai, China). All reagents were analytical or biochemical ones. All TopPette Pipettors (2~20 μL and 20~200 μL) were purchased from DLAB Scientific Co., Ltd., Beijing, China.
Mueller Hinton agar (MHA) consisted of casein hydrolysate at 17.5 g/L, starch soluble at 1.5 g/L, beef extract at 3.0 g/L and agar powder at 17.0 g/L dissolved in purified water, with a pH value of 7.40 ± 0.20. MHB was prepared without agar powder according to the same composition and procedure as MHA.

4.2. Bacterial Strains and Growth Condition

S. aureus ATCC 25923 was purchased from American Type Culture Collection, Manassas, VA, USA, and this organism was stored in Microbank™ microbial storages (PRO-LAB diagnostics, Toronto, ON, Canada) at −20 °C. Prior to use, S. aureus was cultured onto an MHA plate at 37 °C, and then pure colonies from the plate were inoculated into MHB at 37 °C for 24 h on a rotary shaker (160 rpm). A 1:100 dilution of the overnight culture was made into fresh MHB and then incubated at 37 °C until the exponential phase for the following experiments. MHB was used for the antimicrobial susceptibility tests.

4.3. MIC Calculation

The physicochemical parameters LogP of the tested plant flavonoids were calculated using software ACD/Labs 6.0. Then, the average MIC (or MIC90) values of these compounds against Gram-positive bacteria were predicted according to the following Equation (1) [15].
y = −0.1285 x6 + 0.7944 x5 + 51.785 x4 − 947.64 x3 + 6638.7 x2 – 21,273 x + 26,087
where y is the average MIC (or MIC90) value of a certain flavonoid to Gram-positive bacteria, mainly including S. aureus, S. epidermidis and B. subtilis; x is the physicochemical parameter LogP value of this compound.

4.4. Antimicrobial Susceptibility Assay

According to the standard procedure described by the Clinical and Laboratory Standards Institute (CLSI) [31], the exponential phase culture was diluted with MHB to achieve an S. aureus concentration of approximately 1.0 × 106 CFU/mL, and then the susceptibility of the plant flavonoids against S. aureus ATCC 25923 was determined using the broth microdilution method on the 96-well plates (Shanghai Excell Biological Technology Co., Ltd., Shanghai, China) in triplicate [4]. Referring to the calculated MIC values of plant flavonoids, the initial concentration of each compound was set. After the 96-well plates were incubated at 35 °C for 24 h, 20 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 4.0 mg/mL) was added into each well, shaken well, and kept for 30 min at an ambient temperature. The minimum inhibitory concentration (MIC), defined as the lowest concentration of compounds that completely inhibited bacterial growth in the micro-wells, was judged from there being no color change when the bacterial growth in blank wells was sufficient [32].

4.5. Influences of MK−4 on Plant Flavonoids against S. aureus

Using the checkerboard method referring to our previous work [4], the influences of MK−4 on plant flavonoids against S. aureus were evaluated from the combined antimicrobial effects of MK−4 and each compound. Briefly, a series of concentrations from 8 to 1024 μg/mL of test compounds (Figure 1) and MK−4, respectively, in the horizontal or vertical direction were prepared with MHB medium in a separate 96-well plate using the twofold dilution method. Next, 50 μL of the test compound or MK−4 with different concentrations was correspondingly added into the designed wells on another plate to obtain different proportions with test compounds (Figure 1) or MK−4 concentrations from 4 to 512 μg/mL, and then 100 μL of bacterial suspension (approximately 1.0 × 106 CFU/mL) was added into each well. In contrast, for compounds 8, 11 and 12 (Figure 1), the final concentrations of test compounds in corresponding wells ranged from 8 to 1024 μg/mL, and those of compound 6 in Figure 1 ranged from 8 to 4096 μg/mL.
In addition, column 11 contained a series of concentrations from 2 to 256 μg/mL of MK−4 in MHB with 5 × 105 cfu/mL S. aureus isolate, which were used as negative controls. Column 12 contained a series of concentrations from 2 to 256 μg/mL for the test compound (1, 2, 10, 13 or 14), from 8 to 1024 μg/mL for the test compound (8, 11 or 12), and from 32 to 4096 μg/mL for compound 6, which were used as accompanying controls, respectively. According to the same procedure as in Section 4.4, the MICs of each flavonoid against S. aureus were determined under the interferences of different MK−4 concentrations.

4.6. Influences of MK Extract on Plant Flavonoids against S. aureus

4.6.1. MK Extract from S. aureus

Referring to the method reported by Schurig-Briccio et al. [33], the MK was extracted from S. aureus ATCC 25923. Briefly, 3000 mL of S. aureus cells at the exponential phase was collected via centrifugation at 3000 rpm for 15 min. The pellet was resuspended with 30 mL of purified water, and then the mixture was crushed by a SCIENTZ-IID ultrasound cell breaker (Ningbo Scientz Biotechnology Co., Ltd., Ningbo, China) for 12 min (2 s treatment and 3 s interval). Next, the mixture was centrifuged at 3000 rpm for 15 min, and the pallet was resuspended with 3 mL of water and extracted with 17.5 mL of methanol/petroleum ether (6:4, v/v) using a vigorous vortex for 1 min (three times). After being kept for 2 h, the mixture was eddied again for another 1 min, followed by centrifuging at 3000 rpm for 10 min. The upper organic layer was transferred to a 10 mL centrifuge tube and was then evaporated under nitrogen stream to obtain a dried and oily residue (marked as the MK extract).

4.6.2. HPLC-UV Analyses for the MK Extract

A standard solution (35.0 μg/mL) of MK−4 and a sample solution (128.0 μg/mL) of the MK extract were prepared using methanol/isopropanol (60:40, v/v). Simultaneously, both the above solutions were mixed in equal volume to obtain a mixed solution of MK−4 plus MK extract, and MK−4 was used as an internal standard. Referring to our previous work [19], the menaquinones contained in the MK extract were analyzed using a HPLC-UV method without methodological validation. Briefly, the HPLC-UV analyses were performed on a Waters e2695 separation system consisting of a model 2998 ultraviolet detector (Milford, MA, USA), and the detection wavelength was set at 247 nm. A Hypersil ODS2 (4.6 mm × 250 mm, 5.0 µm) (Dalian Elite Analytical Instruments Co., Ltd., Dalian, China) was used as the chromatographic column which was kept at room temperature throughout the experiments. Methanol/isopropanol (60:40, v/v) was used as the mobile phase, and the flow rate was set at 1.0 mL/min, along with an injection volume of 20 μL. After injection into the HPLC system, the main MKs in the MK extract were identified from the UV spectral characteristics of all chromatographic peaks in the HPLC profile of the mixed solution (Figure 3 and Figure S1), according to our previous publication [19]. In detail, based on the UV spectral characteristics, MK analogs were identified if a chromatographic peak in the HPLC profile of the mixed solution had a similar UV absorption curve to that of the MK−4.

4.6.3. MICs of Plant Flavonoids with the Interference of the MK Extract

According to the method and procedure in Section 4.5, the MICs of plant flavonoids with the interference of the MK extract were determined using a checkerboard method. In contrast, a series of concentrations from 16 to 2048 μg/mL of the MK extract in the vertical direction were prepared with MHB medium in a separate 96-well plate using the twofold dilution method, and the final concentrations of the MK extract ranged from 4 to 512 μg/mL. In addition, column 11 contained a series of concentrations from 4 to 512 μg/mL of the MK extract in MHB with 5 × 105 cfu/mL S. aureus isolate, which were used as negative controls.

5. Conclusions

Compared with our previous work showing that plant flavonoids mainly act on the cell membrane of Gram-positive bacteria likely involving the respiratory inhibition, here it was concluded that the quinone pool is a key target of plant flavonoids inhibiting Gram-positive bacteria, which likely involves multiple mechanisms including some enzyme and non-enzyme inhibitions. Moreover, it plays a key role for the antibacterial activities of plant flavonoids in ensuring that they have enough lipophilicity to locate the cell membranes of Gram-positive bacteria and thus target the quinone pool on the respiratory chain.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28134972/s1, Figure S1: The HPLC-UV profiles of representative MK extract from S. aureus ATCC 25923.

Author Contributions

Conceptualization, G.Y.; methodology, G.Y.; software, L.Z., Y.Y., J.Z. and G.Y.; validation, G.Y., L.Z., Y.Y. and J.Z.; formal analysis, G.Y., L.Z., Y.Y., X.X. and J.Z.; investigation, L.Z., Y.Y., J.Z., X.X., G.Y., S.L., B.D. and X.L.; resources, G.Y.; data curation, G.Y., L.Z., Y.Y., J.Z., X.X., S.L. and B.D.; writing—original draft preparation, G.Y., L.Z., Y.Y. and J.Z.; writing—review and editing, G.Y., X.X., S.L., B.D. and X.L.; visualization, G.Y., L.Z., J.Z., Y.Y. and X.L.; supervision, G.Y.; project administration, G.Y.; funding acquisition, G.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China, grant numbers 81960636 and 82073745.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Murray, C.J.L.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Aguilar, G.R.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef]
  2. Laxminarayan, R.; Sridhar, D.; Blaser, M.; Wang, M.; Woolhouse, M. Achieving global targets for antimicrobial resistance. Science 2016, 353, 874–875. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Kurosu, M.; Siricilla, S.; Mitachi, K. Advances in MRSA drug discovery: Where are we and where do we need to be? Exp. Opin. Drug Discov. 2013, 8, 1095–1116. [Google Scholar] [CrossRef] [Green Version]
  4. Xu, X.; Xu, L.; Yuan, G.; Wang, Y.; Qu, Y.; Zhou, M. Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance. Sci. Rep. 2018, 8, 7237. [Google Scholar] [CrossRef] [PubMed]
  5. Liang, M.; Ge, X.; Xua, H.; Ma, K.; Zhang, W.; Zan, Y.; Efferth, T.; Xue, Z.; Hua, X. Phytochemicals with activity against methicillin-resistant Staphylococcus aureus. Phytomedicine 2022, 100, 154073. [Google Scholar] [CrossRef] [PubMed]
  6. Panda, L.; Duarte-Sierra, A. Recent advancements in enhancing antimicrobial activity of plant-derived polyphenols by biochemical means. Horticulturae 2022, 8, 401. [Google Scholar] [CrossRef]
  7. Xie, Y.; Yang, W.; Tang, F.; Chen, X.; Ren, L. Antibacterial activities of flavonoids: Structure-activity relationship and mechanism. Curr. Med. Chem. 2015, 22, 132–149. [Google Scholar] [CrossRef]
  8. Tan, Z.; Deng, J.; Ye, Q.; Zhang, Z. The antibacterial activity of natural-derived flavonoids. Curr. Top. Med. Chem. 2022, 22, 1009–1019. [Google Scholar] [CrossRef]
  9. Song, L.; Hu, X.; Ren, X.; Liu, J.; Liu, X. Antibacterial modes of herbal flavonoids combat resistant bacteria. Front. Pharmacol. 2022, 13, 873374. [Google Scholar] [CrossRef]
  10. Wu, S.C.; Yang, Z.Q.; Liu, F.; Peng, W.J.; Qu, S.Q.; Li, Q.; Song, X.B.; Zhu, K.; Shen, J.Z. Antibacterial effect and mode of action of flavonoids from licorice against methicillin-resistant Staphylococcus aureus. Front. Microbiol. 2019, 10, 2489. [Google Scholar] [CrossRef] [Green Version]
  11. Zhou, K.; Yang, S.; Li, S.M. Naturally occurring prenylated chalcones from plants: Structural diversity, distribution, activities and biosynthesis. Nat. Prod. Rep. 2021, 38, 2236–2260. [Google Scholar] [CrossRef]
  12. Górniak, I.; Bartoszewski, R.; Króliczewski, J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochem. Rev. 2019, 18, 241–272. [Google Scholar] [CrossRef] [Green Version]
  13. Farhadi, F.; Khameneh, B.; Iranshahi, M.; Iranshahy, M. Antibacterial activity of flavonoids and their structure-activity relationship: An update review. Phytother. Res. 2019, 33, 13–40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Yuan, G.; Guan, Y.; Yi, H.; Lai, S.; Sun, Y.; Cao, S. Antibacterial activity and mechanism of plant flavonoids to gram-positive bacteria predicted from their lipophilicities. Sci. Rep. 2021, 11, 10471. [Google Scholar] [CrossRef]
  15. Yuan, G.; Xia, X.; Guan, Y.; Yi, H.; Lai, S.; Sun, Y.; Cao, S. Antimicrobial quantitative relationship and mechanism of plant flavonoids to gram-positive bacteria. Pharmaceuticals 2022, 15, 1190. [Google Scholar] [CrossRef]
  16. Paudel, A.; Hamamoto, H.; Panthee, S.; Sekimizu, K. Menaquinone as a potential target of antibacterial agents. Drug Discov. Ther. 2016, 10, 123–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Kurosu, M.; Begari, E. Vitamin K2 in electron transport system: Are enzymes involved in vitamin K2 biosynthesis promising drug targets? Molecules 2010, 15, 1531–1553. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Hamamoto, H.; Urai, M.; Ishii, K.; Yasukawa, J.; Paudel, A.; Murai, M.; Kaji, T.; Kuranaga, T.; Hamase, K.; Katsu, T.; et al. Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nat. Chem. Biol. 2015, 11, 127–133. [Google Scholar] [CrossRef]
  19. Cao, S.; Du, X.; Li, P.; Yuan, G.; Chen, S.; Chen, W.; Song, X.; Kuang, B. A chemical screening method for menaquinone-producing strains based on HPLC-UV technology. J. Microbiol. Methods 2020, 172, 105907. [Google Scholar] [CrossRef]
  20. Shamsudin, N.F.; Ahmed, Q.U.; Mahmood, S.; Ali Shah, S.A.; Khatib, A.; Mukhtar, S.; Alsharif, M.A.; Parveen, H.; Zakaria, Z.A. Antibacterial effects of flavonoids and their structure-activity relationship study: A comparative interpretation. Molecules 2022, 27, 1149. [Google Scholar] [CrossRef]
  21. Jeong, K.; Lee, J.; Kang, D.; Lee, J.; Shin, S.Y.; Kim, Y. Screening of flavonoids as candidate antibiotics against Enterococcus faecalis. J. Nat. Prod. 2009, 72, 719–724. [Google Scholar] [CrossRef]
  22. Wu, D.; Kong, Y.; Han, C.; Chen, J.; Hu, L.; Jiang, H.; Shen, X. D-Alanine: D-alanine ligase as a new target for the flavonoids quercetin and apigenin. Int. J. Antimicrob. Agents 2008, 32, 421–426. [Google Scholar] [CrossRef]
  23. Elmasri, W.A.; Zhu, R.; Peng, W.; Al-Hariri, M.; Kobeissy, F.; Tran, P.; Hamood, A.N.; Hegazy, M.F.; Paré, P.W.; Mechref, Y. Multitargeted flavonoid inhibition of the pathogenic bacterium Staphylococcus aureus: A proteomic characterization. J. Proteome Res. 2017, 16, 2579–2586. [Google Scholar] [CrossRef]
  24. Ohemeng, K.A.; Schwender, C.F.; Fu, K.P.; Barrett, J.F. DNA gyrase inhibitory and antibacterial activity of some flavones (l). Bioorg. Med. Chem. Lett. 1993, 3, 225–230. [Google Scholar] [CrossRef]
  25. Iinuma, M.; Tosa, H.; Tanaka, T.; Asai, F.; Kobayashi, Y.; Shimano, R.; Miyauchi, K. Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylococcus aureus. J. Pharm. Pharmacol. 1996, 48, 861–865. [Google Scholar] [CrossRef] [PubMed]
  26. Wang, M.H.; Zhang, K.J.; Gu, Q.L.; Bi, X.L.; Wang, J.X. Pharmacology of mangostins and their derivatives: A comprehensive review. Chin. J. Nat. Med. 2017, 15, 81–93. [Google Scholar] [CrossRef] [PubMed]
  27. Song, M.; Liu, Y.; Li, T.; Liu, X.; Hao, Z.; Ding, S.; Panichayupakaranant, P.; Zhu, K.; Shen, J. Plant natural flavonoids against multidrug resistant pathogens. Adv. Sci. 2021, 8, e2100749. [Google Scholar] [CrossRef]
  28. Lin, S.; Zhu, C.; Li, H.; Chen, Y.; Liu, S. Potent in vitro and in vivo antimicrobial activity of semisynthetic amphiphilic γ-mangostin derivative LS02 against Gram-positive bacteria with destructive effect on bacterial membrane. Biochim. Biophys. Acta Biomembr. 2020, 1862, 183353. [Google Scholar] [CrossRef] [PubMed]
  29. Koh, J.J.; Qiu, S.; Zou, H.; Lakshminarayanan, R.; Li, J.; Zhou, X.; Tang, C.; Saraswathi, P.; Verma, C.; Tan, D.T.; et al. Rapid bactericidal action of α-mangostin against MRSA as an outcome of membrane targeting. Biochim. Biophys. Acta 2013, 1828, 834–844. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Haraguchi, H.; Tanimoto, K.; Tamura, Y.; Mizutani, K.; Kinoshita, T. Mode of antibacterial action of retrochalcones from Glycyrrhiza inflata. Phytochemistry 1998, 48, 125–129. [Google Scholar] [CrossRef]
  31. Clinical and Laboratory and Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 10th ed.; Approved Standards, CLSI Document M07-A10; Clinical and Laboratory and Standards Institute: Wayne, PA, USA, 2015. [Google Scholar]
  32. Wu, X.; Xu, L.; Li, P.; Wang, Y.; Yuan, G. The anti-methicillin-resistant Staphylococcus aureus activities of azalomycin F derivatives and those of them combined with vitamin K3. Chin. J. Antibiot. 2016, 41, 584–589. [Google Scholar]
  33. Schurig-Briccio, L.A.; Yano, T.; Rubin, H.; Gennis, R.B. Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines. Biochim. Biophys. Acta. 2014, 1837, 954–963. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Molecules 28 04972 g001 550
Figure 1. The chemical structures of twelve compounds with seven subtypes of plant flavonoids. 1, Kurarinone; 2, Sophoraflavanone G; 3, Naringenin; 4, Galangin; 5, Quercetin; 6, Baicalein; 7, Formononetin; 8, Licochalcone A; 9, Echinatin; 10, Isoliquiritigenin; 11, Glabridin; 12, α-Mangostin.
Figure 1. The chemical structures of twelve compounds with seven subtypes of plant flavonoids. 1, Kurarinone; 2, Sophoraflavanone G; 3, Naringenin; 4, Galangin; 5, Quercetin; 6, Baicalein; 7, Formononetin; 8, Licochalcone A; 9, Echinatin; 10, Isoliquiritigenin; 11, Glabridin; 12, α-Mangostin.
Molecules 28 04972 g001
Molecules 28 04972 g002 550
Figure 2. The influences of MK−4 on plant flavonoids against S. aureus ATCC 25923. (a), α-Mangostin; (b), Sophoraflavanone G; (c), Licochalcone A; (d), Kurarinone; (e), Glabridin; (f), Isoliquiritigenin; (g), Baicalein; (h), Echinatin; (i), Quercetin. Each compound was tested in triple, and tests 1, 2 and 3, respectively, showed the red, blue and green lines in the planes (sometimes the red, blue and/or green lines overlapped and only showed as the red, blue or green lines). Those lines without data dots in (f–h) indicated that the MICs were more than 1024 μg/mL.
Figure 2. The influences of MK−4 on plant flavonoids against S. aureus ATCC 25923. (a), α-Mangostin; (b), Sophoraflavanone G; (c), Licochalcone A; (d), Kurarinone; (e), Glabridin; (f), Isoliquiritigenin; (g), Baicalein; (h), Echinatin; (i), Quercetin. Each compound was tested in triple, and tests 1, 2 and 3, respectively, showed the red, blue and green lines in the planes (sometimes the red, blue and/or green lines overlapped and only showed as the red, blue or green lines). Those lines without data dots in (f–h) indicated that the MICs were more than 1024 μg/mL.
Molecules 28 04972 g002
Molecules 28 04972 g003 550
Figure 3. The HPLC profile of representative MK extract from S. aureus ATCC 25923. MK−4 was used as an internal standard, and peaks 1, 2 and 3 corresponded to MK−7, −8 and −9, respectively.
Figure 3. The HPLC profile of representative MK extract from S. aureus ATCC 25923. MK−4 was used as an internal standard, and peaks 1, 2 and 3 corresponded to MK−7, −8 and −9, respectively.
Molecules 28 04972 g003
Molecules 28 04972 g004 550
Figure 4. The influences of MK extract on plant flavonoids against S. aureus ATCC 25923. (a), α-Mangostin; (b), Sophoraflavanone G; (c), Licochalcone A; (d), Kurarinone; (e), Glabridin; (f), Isoliquiritigenin; (g), Baicalein; (h), Echinatin; (i), Quercetin. Each compound was tested in triple, and tests 1, 2 and 3, respectively, showed the red, blue and green lines in the planes (sometimes the red, blue and/or green lines overlapped and only showed as the red, blue or green lines). Those lines without data dot in (f–h) indicated the MICs were more than 1024 μg/mL.
Figure 4. The influences of MK extract on plant flavonoids against S. aureus ATCC 25923. (a), α-Mangostin; (b), Sophoraflavanone G; (c), Licochalcone A; (d), Kurarinone; (e), Glabridin; (f), Isoliquiritigenin; (g), Baicalein; (h), Echinatin; (i), Quercetin. Each compound was tested in triple, and tests 1, 2 and 3, respectively, showed the red, blue and green lines in the planes (sometimes the red, blue and/or green lines overlapped and only showed as the red, blue or green lines). Those lines without data dot in (f–h) indicated the MICs were more than 1024 μg/mL.
Molecules 28 04972 g004
Table
Table 1. Minimum inhibitory concentrations (MICs) of twelve plant flavonoids against Gram-positive bacteria.
Table 1. Minimum inhibitory concentrations (MICs) of twelve plant flavonoids against Gram-positive bacteria.
CompoundsLogPCalculated MICs aTested MICs (μg/mL) bCompoundsLogPCalculated MICsTested MICs
(μg/mL)
μmol/Lμg/mLμmol/Lμg/mL
Kurarinone6.3028.9212.678Formononetin3.15549.61147.35˃1024
Sophoraflavanone G6.5216.376.952~4Licochalcone A4.9574.4425.174
Naringenin3.19509.64138.67512Echinatin3.23472.20127.54˃1024
Galangin2.83974.47263.15>1024Isoliquiritigenin3.40338.7886.76512~1024
Quercetin2.073063.61925.214096Glabridin4.3974.7424.388~16
Baicalein3.31404.47109.23512~˃1024α-Mangostin6.708.173.352
a: Considered as the average MIC (or MIC90) values of plant flavonoids against Gram-positive bacteria such as S. aureus, S. epidermidis and B. subtilis were calculated from Equation (1); b: the MIC values of plant flavonoids against S. aureus ATCC 25923 were determined in triplicate.
Table
Table 2. The MIC changes of plant flavonoids against S. aureus after interfering with maximum test concentrations of MK−4 and MK extract a.
Table 2. The MIC changes of plant flavonoids against S. aureus after interfering with maximum test concentrations of MK−4 and MK extract a.
CompoundsMICAlone
(μg/mL)		MIC Change (Times) bCompoundsMICAlone
(μg/mL)		MIC Change (Times)
MK−4MK ExtractMK−4MK Extract
α-Mangostin2168~16Isoliquiritigenin512~˃10242/- c1
Sophoraflavanone G2~44~84~8Baicalein512~˃1024--
Licochalcone A444~8Echinatin˃1024--
Kurarinone82~42~4Quercetin409611
Glabridin8~162~42~4
a: The test microorganism is S. aureus ATCC 25923; b: the interfering concentrations of MK−4 and MK extract were 256 and 512 μg/mL, respectively; c: - indicated that the increased times were uncertain since no definite MIC value was obtained.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, L.; Yan, Y.; Zhu, J.; Xia, X.; Yuan, G.; Li, S.; Deng, B.; Luo, X. Quinone Pool, a Key Target of Plant Flavonoids Inhibiting Gram-Positive Bacteria. Molecules 2023, 28, 4972. https://doi.org/10.3390/molecules28134972

AMA Style

Zhang L, Yan Y, Zhu J, Xia X, Yuan G, Li S, Deng B, Luo X. Quinone Pool, a Key Target of Plant Flavonoids Inhibiting Gram-Positive Bacteria. Molecules. 2023; 28(13):4972. https://doi.org/10.3390/molecules28134972

Chicago/Turabian Style

Zhang, Li, Yu Yan, Jianping Zhu, Xuexue Xia, Ganjun Yuan, Shimin Li, Beibei Deng, and Xinrong Luo. 2023. "Quinone Pool, a Key Target of Plant Flavonoids Inhibiting Gram-Positive Bacteria" Molecules 28, no. 13: 4972. https://doi.org/10.3390/molecules28134972

APA Style

Zhang, L., Yan, Y., Zhu, J., Xia, X., Yuan, G., Li, S., Deng, B., & Luo, X. (2023). Quinone Pool, a Key Target of Plant Flavonoids Inhibiting Gram-Positive Bacteria. Molecules, 28(13), 4972. https://doi.org/10.3390/molecules28134972

Article Metrics

Back to TopTop